Data on WaferGen's SmartChip(TM) System Presented at 16th International Molecular Medicine Tri-...(erable excitement among our team. We ex...)

Date:2/25/2009

erable excitement among our team. We expect that this excitement will be shared by current collaborators and potential customers," stated Alnoor Shivji, WaferGen's chairman and chief executive officer. "We are pleased to have had the opportunity to present these important validation results for the SmartChip system at a highly-regarded scientific conference. We continue to be encouraged by the performance of the SmartChip system in this rigorous scientific testing program."

WaferGen's SmartChip alpha testing program, which is being conducted at the University of Pittsburgh School of Medicine, involves the study of RNA isolated from lung tissue samples from healthy patients, as well as patients with chronic obstructive pulmonary disease (COPD) and IPF. Researchers are screening these RNA samples with the SmartChip Real-Time PCR System in order to assess the platform's performance in conducting novel gene expression research. The next phase of the alpha testing program will focus on using the SmartChip system to identify biomarkers of interest.

About the SmartChip Real-Time PCR System

The SmartChip Real-Time PCR System(TM) is designed as the first whole genome, high-throughput gene expression real-time PCR platform. This innovative system, combined with next-generation chemistry and optimized assays being developed by WaferGen, promises to deliver significant speed and cost advantages to researchers in the gene expression and genotyping markets. Based on collaborations established with leading research institutions, WaferGen believes that the SmartChip Real-Time PCR System is positioned as the platform of choice for biomarker discovery and validation. It is estimated that the genetic analysis market alone (comprised of gene expression and genotyping analysis) had approximately $2.4 billion in worldwide revenues in 2006 ($1.74 billion for gene expression and $650 million for genotyping). Total
'/>"/>

SOURCE WaferGen Biosystems, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5
Related biology technology :

1. WaferGens SmartChip(TM) System Performance Successfully Demonstrated in Initial Phase of Alpha Testing Program
2. NIH Awards Approximately $3M Grant for Research Involving WaferGens SmartChip(TM) Real-Time PCR System at the University of Pittsburgh
3. Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System
4. Innovative Biosensors and ProGenTech Partner to Develop a Rapid Diagnostics System
5. CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas
6. Data on WaferGens SmartChip Real-Time PCR System(TM) to be Presented at 16th International Molecular Medicine Tri-Conference
7. MaxCyte Introduces the GT(TM) Flow Transfection System for Application with Autologous and Allogeneic Stem Cell Therapies
8. Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon
9. Proximity Systems LAN Based Electronic Lock Management System Offers Increased Security, Efficiency and Reporting Capability for Wall-Mounted WorkStations
10. XenoTech LLC Offers Drug Industry New Metabolite Profiling Services Following Acquisition of Waters Synapt HDMS System
11. Avid Bioservices Presents Data From Manufacturing Successes Achieved With Single-Use Bioreactor Systems